Sunstone backs Forendo
Forendo Pharma, a Finnish drug developer focused on women's health, has secured 5 million euros in funding. The investor was Sunstone Life Science Ventures. In addition to the funding, Claus Andersson, a general partner from Sunstone, joins Forendo Pharma's board of directors.
19 July 2019•1 min read
